ActiQs / Research

PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ribavirin. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

15 hits

Bibliografisk träff 2018-04-03

Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes.

Ostrov DA, Alkanani A, McDaniel KA, Case S, Baschal EE, Pyle L, Ellis S, Pöllinger B, Seidl KJ, Shah VN, Garg SK, Atkinson MA, Gottlieb PA, Michels AW.

J Clin Invest · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1172/jci97739

Bibliografisk träff 2012-03-13

Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.

Milazzo L, Foschi A, Mazzali C, Viola A, Ridolfo A, Galli M, Antinori S.

AIDS Res Hum Retroviruses · research support, non-u.s. gov't; journal article · DOI 10.1089/aid.2011.0323

Bibliografisk träff 2012-02-01

New targets for antiviral therapy of chronic hepatitis C.

Bühler S, Bartenschlager R.

Liver Int · research support, non-u.s. gov't; review; journal article · DOI 10.1111/j.1478-3231.2011.02701.x

Bibliografisk träff 2012-02-01

Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1.

Manns MP, Markova AA, Calle Serrano B, Cornberg M.

Liver Int · review; journal article · DOI 10.1111/j.1478-3231.2011.02725.x

Bibliografisk träff 2012-02-01

Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice.

Hézode C.

Liver Int · review; journal article · DOI 10.1111/j.1478-3231.2011.02707.x

Bibliografisk träff 2012-02-01

Triple therapy with boceprevir for HCV genotype 1 infection: phase III results in relapsers and nonresponders.

Bacon BR, Khalid O.

Liver Int · review; journal article · DOI 10.1111/j.1478-3231.2011.02700.x

Bibliografisk träff 2012-02-01

IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?

Jensen DM, Pol S.

Liver Int · review; journal article · DOI 10.1111/j.1478-3231.2011.02712.x

Bibliografisk träff 2012-02-01

The role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis C.

Clark V, Nelson DR.

Liver Int · research-article; review; journal article; research support, n.i.h., extramural · DOI 10.1111/j.1478-3231.2011.02711.x

Bibliografisk träff 2011-12-09

Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes.

Naggie S, Rallon NI, Benito JM, Morello J, Rodriguez-Novoa S, Clark PJ, Thompson AJ, Shianna KV, Vispo E, McHutchison JG, Goldstein DB, Soriano V.

J Infect Dis · research-article; journal article; research support, n.i.h., extramural · DOI 10.1093/infdis/jir754

Bibliografisk träff 2011-12-07

Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.

Butt AA, Kanwal F.

Clin Infect Dis · research support, non-u.s. gov't; review; journal article · DOI 10.1093/cid/cir774

Bibliografisk träff 2011-11-08

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C.

Hayashi N, Okanoue T, Tsubouchi H, Toyota J, Chayama K, Kumada H.

J Viral Hepat · clinical trial, phase iii; research-article; journal article · DOI 10.1111/j.1365-2893.2011.01528.x

Bibliografisk träff 2011-11-02

Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients.

Nishimura T, Osaki R, Shioya M, Imaeda H, Aomatsu T, Takeuchi T, Okumura Y, Fujiyama Y, Andoh A.

Mol Med Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/mmr.2011.659

Bibliografisk träff 2011-11-01

Interleukin-28B genotypes determine response to pegylated-interferon plus ribavirin therapy in patients with hepatitis C virus infection.

Osaki R, Nishimura T, Shioya M, Takeuchi T, Okumura Y, Nakahara T, Bamba S, Nakajo S, Fujiyama Y, Andoh A.

Mol Med Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/mmr.2011.655

Bibliografisk träff 2011-10-30

Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta-analysis.

Alavian SM, Tabatabaei SV, Behnava B.

J Viral Hepat · meta-analysis; systematic review; journal article · DOI 10.1111/j.1365-2893.2011.01532.x

Bibliografisk träff 2011-08-07

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan.

Kumada H, Toyota J, Okanoue T, Chayama K, Tsubouchi H, Hayashi N.

J Hepatol · multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.jhep.2011.07.016